Carmen Gutiérrez-rekin lankidetzan egindako argitalpenak (39)

2014

  1. Lack of replication of higher genetic risk load in men than in women with systemic lupus erythematosus

    Arthritis Research and Therapy, Vol. 16, Núm. 3

2012

  1. Further Evidence of Subphenotype Association with Systemic Lupus Erythematosus Susceptibility Loci: A European Cases Only Study

    PLoS ONE, Vol. 7, Núm. 9

2011

  1. Dexamethasone upregulates FOXP3 expression without increasing regulatory activity

    Immunobiology, Vol. 216, Núm. 3, pp. 386-392

2010

  1. A case of polymyositis associated with the presence of anti-proliferating cell nuclear antigen antibodies, a marker typically considered SLE specific

    Lupus

  2. Cytokines and regulatory T cells in rheumatoid arthritis and their relationship with response to corticosteroids

    Journal of Rheumatology, Vol. 37, Núm. 12, pp. 2502-2510

  3. IL-10 and TNFα genotypes in SLE

    Journal of Biomedicine and Biotechnology, Vol. 2010

  4. Interleukin 10 and tumor necrosis factor-α genotypes in rheumatoid arthritis - Association with clinical response to glucocorticoids

    Journal of Rheumatology, Vol. 37, Núm. 3, pp. 503-511

2009

  1. Conserved anti-proliferative effect and poor inhibition of TNFα secretion by regulatory CD4+CD25+ T cells in patients with systemic lupus erythematosus

    Clinical Immunology, Vol. 132, Núm. 3, pp. 385-392

  2. Investigation of TLR5 and TLR7 as candidate genes for susceptibility to systemic lupus erythematosus

    Clinical and Experimental Rheumatology

  3. No evidence for genetic association of interferon regulatory factor 3 in systemic lupus erythematosus

    Lupus, Vol. 18, Núm. 3, pp. 230-234

  4. Replication of recently identified systemic lupus erythematosus genetic associations: A case-control study

    Arthritis Research and Therapy, Vol. 11, Núm. 3

  5. STAT4 associates with systemic lupus erythematosus through two independent effects that correlate with gene expression and act additively with IRF5 to increase risk

    Annals of the Rheumatic Diseases, Vol. 68, Núm. 11, pp. 1746-1753

2008

  1. Functional variants in the B-cell gene BANK1 are associated with systemic lupus erythematosus

    Nature Genetics, Vol. 40, Núm. 2, pp. 211-216

  2. Functional variants in the B-cell gene BANK1 are associated with systemic lupus erythematosus (Nature Genetics (2008) 40, (211-216))

    Nature Genetics

  3. IFNα treatment generates antigen-presenting cells insensitive to atorvastatin inhibition of MHC-II expression

    Clinical Immunology, Vol. 129, Núm. 2, pp. 350-359

  4. Influence of functional interleukin 10/tumor necrosis factor-α polymorphisms on interferon-α, IL-10, and regulatory T cell population in patients with systemic lupus erythematosus receiving antimalarial treatment

    Journal of Rheumatology, Vol. 35, Núm. 8, pp. 1559-1566

  5. Value of measuring plasmatic levels of neurosin in the diagnosis of Alzheimer's disease

    Journal of Alzheimer's Disease, Vol. 14, Núm. 1, pp. 59-67

2007

  1. Association of IL-10 and TNFα genotypes with ANCA appearance in ulcerative colitis

    Clinical Immunology, Vol. 122, Núm. 1, pp. 108-114

  2. Structural insertion/deletion variation in IRF5 is associated with a risk haplotype and defines the precise IRF5 isoforms expressed in systemic lupus erythematosus

    Arthritis and Rheumatism, Vol. 56, Núm. 4, pp. 1234-1241

2006

  1. Cytokine polymorphisms influence treatment outcomes in SLE patients treated with antimalarial drugs

    Arthritis Research and Therapy, Vol. 8, Núm. 2